English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 905252      Online Users : 938
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Collection

    會議論文/會議摘要 [2/2]
    期刊論文 [22/23]

    Community Statistics


    近3年內發表的文件:0(0.00%)
    含全文筆數:24(96.00%)

    文件下載次數統計
    下載大於0次:24(100.00%)
    下載大於100次:24(100.00%)
    檔案下載總次數:13159(0.25%)

    最後更新時間: 2024-12-01 03:13

    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 1-10 of 25. (3 Page(s) Totally)
    1 2 3 > >>
    View [10|25|50] records per page

    DateTitleRelation
    2020-01 Deacetylation of HSPA5 by HDAC6 leads to GP78-mediated HSPA5 ubiquitination at K447 and suppresses metastasis of breast cancer [Erraturm: Oncogene. 2016 May;35(12):1517-1528.] Oncogene. 2020 Jan;39(4):946-949.
    2017-12 E1A-mediated inhibition of HSPA5 suppresses cell migration and invasion in triple-negative breast cancer [Erratum: Annals of Surgical Oncology. 2015;22(3):889-898.] Annals of Surgical Oncology. 2017 Dec;24(Suppl. 3):685-686.
    2017-04 The STAT3-miRNA-92-Wnt signaling pathway regulates spheroid formation and malignant progression in ovarian cancer Cancer Research. 2017 Apr;77(8):1955-1967.
    2017-01 Targeting the VEGF-C/VEGFR3 axis suppresses Slug-mediated cancer metastasis and stemness via inhibition of KRAS/YAP1 signaling Oncotarget. 2017 Jan;8(3):5603-5618.
    2016-11 Angiopoietin-like protein 1 antagonizes MET receptor activity to repress sorafenib resistance and cancer stemness in hepatocellular carcinoma Hepatology. 2016Nov;64(5):1637-1651.
    2016-09 A novel application of E1A in combination therapy with EGFR-TKI treatment in breast cancer Oncotarget. 2016 Sep;7(39):63924-63936.
    2016-07 Dicer elicits paclitaxel chemosensitization and suppresses cancer stemness in breast cancer by repressing AXL Cancer Research. 2016 Jul;76(13):3916-3928.
    2016-04-18 NF-kappaB-driven suppression of FOXO3a contributes to EGFR mutation-independent gefitinib resistance Proceedings of the National Academy of Sciences of the United States of America. 2016 Apr 18;113(18):E2526-E2535.
    2016-04 Vascular endothelial growth factor-C promotes EGFR-TKIs resistance and cancer stemness via SLUG of non-small cell lung cancer Journal of Thoracic Oncology. 2016 Apr;11(4, Suppl.):S132-133.
    2016-03 miR-520h is crucial for DAPK2 regulation and breast cancer progression Oncogene. 2016 Mar 3;35(9):1134-1142.

    Showing items 1-10 of 25. (3 Page(s) Totally)
    1 2 3 > >>
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback